Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors.

The screening of bioactive compound libraries can be an effective approach for repositioning FDA-approved drugs or discovering new pharmacophores. Hookworms are blood-feeding, intestinal nematode parasites that infect up to 600 million people worldwide. Vaccination with recombinant Ancylostoma ceylanicum macrophage migration inhibitory factor (rAceMIF) provided partial protection from disease, thus establishing a "proof-of-concept" for targeting AceMIF to prevent or treat infection. A high-throughput screen (HTS) against rAceMIF identified six AceMIF-specific inhibitors. A nonsteroidal anti-inflammatory drug (NSAID), sodium meclofenamate, could be tested in an animal model to assess the therapeutic efficacy in treating hookworm disease. Furosemide, an FDA-approved diuretic, exhibited submicromolar inhibition of rAceMIF tautomerase activity. Structure-activity relationships of a pharmacophore based on furosemide included one analog that binds similarly to the active site, yet does not inhibit the Na-K-Cl symporter (NKCC1) responsible for diuretic activity.

[1]  Atsushi Nakagawa,et al.  Crystal structure of the macrophage migration inhibitory factor from rat liver , 1996, Nature Structural Biology.

[2]  F. Cohen,et al.  Hydrogen bonds involving sulfur atoms in proteins , 1991, Proteins.

[3]  Z. Dauter,et al.  Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. , 1996, Biochemistry.

[4]  J. Klein,et al.  Macrophage migration inhibitory factor (MIF) of jawed and jawless fishes: implications for its evolutionary origin. , 2003, Developmental and comparative immunology.

[5]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[6]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Bernhagen,et al.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.

[8]  J. Bernhagen,et al.  A Leishmania Ortholog of Macrophage Migration Inhibitory Factor Modulates Host Macrophage Responses1 , 2008, The Journal of Immunology.

[9]  K. Malik,et al.  Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells. , 1994, Kidney international.

[10]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[11]  Dirk Engels,et al.  Soil-transmitted helminth infections: updating the global picture. , 2003, Trends in parasitology.

[12]  J. Behnke,et al.  Ancylostoma ceylanicum in the hamster: observations on the host-parasite relationship during primary infection. , 1989, Parasitology.

[13]  V. Pavlov,et al.  Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory Factor* , 2007, Journal of Biological Chemistry.

[14]  Elias Lolis,et al.  The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents* , 2002, The Journal of Biological Chemistry.

[15]  Elias Lolis,et al.  Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor , 1998, The EMBO journal.

[16]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[17]  E Lolis,et al.  Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. , 2001, Current opinion in pharmacology.

[18]  M. Cappello,et al.  Hookworm infection: new developments and prospects for control , 2004, Current opinion in infectious diseases.

[19]  Andrea Scozzafava,et al.  Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. , 2009, Bioorganic & medicinal chemistry.

[20]  J. H. Stein,et al.  Clinical pharmacology furosemide and ethacrynic acid , 1968 .

[21]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[22]  John David,et al.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Stephenson,et al.  Malnutrition and parasitic helminth infections , 2000, Parasitology.

[24]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[25]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[26]  J. Puschett.  Sites and Mechanisms of Action of Diuretics in the Kidney , 1981, Journal of clinical pharmacology.

[27]  B. Forbush,et al.  A Regulatory Locus of Phosphorylation in the N Terminus of the Na-K-Cl Cotransporter, NKCC1* , 2002, The Journal of Biological Chemistry.

[28]  Kirk W. Johnson,et al.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast , 2010, Proceedings of the National Academy of Sciences.

[29]  Zhinan Yin,et al.  A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice , 2011, The Journal of Immunology.

[30]  Peter J Hotez,et al.  Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm , 2006, The Lancet.

[31]  Roy J. Vaz,et al.  Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site. , 2010, Bioorganic & medicinal chemistry letters.

[32]  M. Cappello,et al.  Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum. , 2001, The Journal of infectious diseases.

[33]  E. Randinitis,et al.  Pharmacology, Pharmacokinetics, and Therapeutic Use of Meclofenamate Sodium , 1991, The Clinical journal of pain.

[34]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[35]  J. Griffitts,et al.  A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum , 2006, Proceedings of the National Academy of Sciences.

[36]  Brantley R. Herrin,et al.  Dual Nature of the Adaptive Immune System in Lampreys , 2009, Nature.

[37]  J. Bernhagen,et al.  The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor1 , 2009, The Journal of Immunology.

[38]  R. Bucala,et al.  The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.

[39]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[40]  Douglas L. Theobald,et al.  THESEUS: maximum likelihood superpositioning and analysis of macromolecular structures , 2006, Bioinform..

[41]  J. Bernhagen,et al.  Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Valentin A. Pavlov,et al.  Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis. , 2007, Journal of medicinal chemistry.

[43]  L. Savioli,et al.  Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. , 2004, International journal for parasitology.

[44]  Michael Bacher,et al.  ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis* , 2005, Journal of Biological Chemistry.

[45]  C. Kozak,et al.  Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF , 1998, Mammalian Genome.

[46]  J. Bernhagen,et al.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.

[47]  R. Bucala,et al.  Orthologs of macrophage migration inhibitory factor from parasitic nematodes. , 2008, Trends in parasitology.

[48]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[49]  L. Leng,et al.  Structural and Functional Characterization of a Secreted Hookworm Macrophage Migration Inhibitory Factor (MIF) That Interacts with the Human MIF Receptor CD74* , 2007, Journal of Biological Chemistry.

[50]  Peter Björk,et al.  The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase , 1997, FEBS letters.

[51]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[52]  J. Bernhagen,et al.  A Tautomerase-Null Macrophage Migration-Inhibitory Factor (MIF) Gene Knock-In Mouse Model Reveals That Protein Interactions and Not Enzymatic Activity Mediate MIF-Dependent Growth Regulation , 2009, Molecular and Cellular Biology.

[53]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[54]  W. F. Gregory,et al.  MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages , 2009, Journal of leukocyte biology.

[55]  S. S. Dadarkar,et al.  A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis. , 2009, European journal of pharmacology.

[56]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[57]  T. Calandra,et al.  MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.